Carfilzomib, pomalidomide, and dexamethasone
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Carfilzomib, pomalidomide, and dexamethasone, covering 2022-08-22 to 2022-08-22. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study of Carfilzomib, Pomalidomide, and Dexamethasone for Myeloma Patients Who Had Relapsed or Progressed After Carfilzomib, Lenalidomide, and Dexamethasone [Phase 2]